SCHEMBL28298610

SCHEMBL28298610

Ic1ccc(N2CCC=C(N3CCOCC3)C2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.45
▸ ALDH1A1 P00352 4/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ MAPT P10636 3/20 0.39
▸ HTT P42858 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ ABL1 P00519 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ LGMN Q99538 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ ALOX15 P16050 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HPGD P15428 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19533190 0.84 LGMN (0.45) ALDH1A1MEN1MAPTHTTKMT2A
SCHEMBL1432961 0.78 AKR1C3 (0.65) AKR1C3ALDH1A1MEN1MAPTHTT
SCHEMBL19533191 0.78 AKR1C3 (0.52) AKR1C3ALDH1A1MEN1MAPTKMT2A
SCHEMBL17642581 0.72 AKR1C3 (0.57) AKR1C3ALDH1A1MEN1MAPTHTT
SCHEMBL1919863 0.70 AKR1C3 (0.44) AKR1C3ALDH1A1MEN1MAPTHTT
SCHEMBL2883585 0.69 LTA4H (0.67) AKR1C3ALDH1A1MEN1MAPTHTT
SCHEMBL30071064 0.69 — —
SCHEMBL9093746 0.67 LMNA (0.71) ALDH1A1MEN1MAPTHTTKMT2A
SCHEMBL14345952 0.65 AKR1C3 (0.57) AKR1C3ALDH1A1MEN1MAPTHTT
SCHEMBL14862707 0.65 AKR1C3 (0.49) AKR1C3ALDH1A1MEN1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109879798-A A kind of preparation method of the important impurity of Eliquis intermediate 山东新华制药股份有限公司 2019-06-14 — — CN claimed
CN-109879798-A A kind of preparation method of the important impurity of Eliquis intermediate 山东新华制药股份有限公司 2019-06-14 — — CN disclosed
Send feedback